We are delighted to announce our new partnership with University College London Hospitals (UCLH) through our contribution of £500,000 towards their new stem cell transplant unit.
This new facility will enable ground-breaking research and clinical trials to be driven by pioneering staff and internationally renowned experts. In many of the disease areas treated, especially leukaemia, lymphoma and myeloma, bone marrow or stem cell transplant is an important part of the treatment pathway both in standard care and clinical trial settings. As one of the largest stem cell transplant units in Europe, the wide cohort of patients will enable UCLH to conduct research into the effectiveness of transplants in different patient groups at different stages in their disease, as well as providing the supportive care required to minimise side effects and improve patient outcomes.
We are proud to work with UCLH in this important area and wish them the very best in realising their ambition to improve outcomes for patients, whilst increasing the output and improving quality of research in new and existing scientific fields.